NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

VI,

I can certainly agree with some sort of agreement with say CRL where they pay NWBO for the rights to utilize the EDEN unit and become the company's primary supplier of the vaccine in the US and perhaps elsewhere, and perhaps $1 billion or more is paid for that right. What I don't see is NWBO establishing an equity partnership for even 1% of the stock where they receive less than $20 a share. If they did receive $20 a share it would drive the share price to nearly that level. I can't see that happening before the share price is $10 a share, though in some instances companies have paid more.

I do believe that UK approval will move us to the $5 to $10 range, if we're near $10 perhaps a multi-billion dollar equity partnership will be possible.

Gary